CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Works by Abitbol, Jeremie
Results: 5
1
2
A prospective comparison of costs between robotics, laparoscopy, and laparotomy in endometrial cancer among women with Class III obesity or higher.
- Published in:
- Journal of Surgical Oncology, 2022, v. 125, n. 4, p. 747, doi. 10.1002/jso.26769
- By:
- Publication type:
- Article
3
The impact of wait times on oncological outcome in high‐risk patients with endometrial cancer.
- Published in:
- Journal of Surgical Oncology, 2020, v. 122, n. 2, p. 306, doi. 10.1002/jso.25929
- By:
- Publication type:
- Article
4
Carboplatin plus paclitaxel weekly dose‐dense chemotherapy for high‐grade ovarian cancer: A re‐evaluation.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2021, v. 100, n. 3, p. 453, doi. 10.1111/aogs.14023
- By:
- Publication type:
- Article
5
Multiple lines of chemotherapy for patients with high‐grade ovarian cancer: Predictors for response and effect on survival.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 9, p. 2304, doi. 10.1002/ijc.33395
- By:
- Publication type:
- Article